BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32897764)

  • 21. Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer.
    Huang YB; Li WL; Sun M; Duan X; Wang YT; Zhang LX; Xin ZH; Yun ZF; Fan B; Li XC
    Asian J Androl; 2023; 25(3):366-374. PubMed ID: 35915542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].
    Manolache NG; Mjaess G; Diamand R; Albisinni S; Roumeguère T
    Prog Urol; 2022 Dec; 32(16):1421-1430. PubMed ID: 36163317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database.
    Dambal S; Howard LE; Allott EH; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ
    J Urol; 2020 Jan; 203(1):120-127. PubMed ID: 31430247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
    Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
    J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer.
    Timilshina N; Breunis H; Alibhai SM
    J Urol; 2012 Dec; 188(6):2183-8. PubMed ID: 23083859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of androgen deprivation therapy on periodontal disease in men with prostate cancer.
    Famili P; Cauley JA; Greenspan SL
    J Urol; 2007 Mar; 177(3):921-4. PubMed ID: 17296376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.
    Ianhez M; Ramos PM; Goren A; Miot HA
    Dermatol Ther; 2020 Nov; 33(6):e14166. PubMed ID: 32772478
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of Androgen-Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients.
    Ünlü S; Shin JJ; Par-Young J; Simonov M; Vinetz J; Petrylak DP; Kang I; Kim JW
    Cancer Invest; 2023 Jan; 41(1):77-83. PubMed ID: 36373994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
    Cary KC; Singla N; Cowan JE; Carroll PR; Cooperberg MR
    J Urol; 2014 Apr; 191(4):964-70. PubMed ID: 24184370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19.
    Bravaccini S; Fonzi E; Tebaldi M; Angeli D; Martinelli G; Nicolini F; Parrella P; Mazza M
    Cell Transplant; 2021; 30():963689721991477. PubMed ID: 33522308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.
    Tsai HT; Keating NL; Van Den Eeden SK; Haque R; Cassidy-Bushrow AE; Ulcickas Yood M; Smith MR; Potosky AL
    J Urol; 2015 Jun; 193(6):1956-62. PubMed ID: 25524243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
    Fu AZ; Tsai HT; Haque R; Yood MU; Cassidy-Bushrow AE; Van Den Eeden SK; Keating NL; Smith MR; Zhou Y; Aaronson DS; Potosky AL
    J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study.
    Kim DK; Lee HS; Park JY; Kim JW; Hah YS; Ha JS; Kim JH; Cho KS
    Urol Oncol; 2022 Jan; 40(1):6.e11-6.e19. PubMed ID: 34315660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer.
    Gedeborg R; Lindhagen L; Loeb S; Styrke J; Garmo H; Stattin P
    Scand J Urol; 2022 Apr; 56(2):104-111. PubMed ID: 34939533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer.
    Takizawa I; Hara N; Nishiyama T; Isahaya E; Hoshii T; Takahashi K
    J Urol; 2010 Nov; 184(5):1971-6. PubMed ID: 20884032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
    Sun M; Cole AP; Hanna N; Mucci LA; Berry DL; Basaria S; Ahern DK; Kibel AS; Choueiri TK; Trinh QD
    J Urol; 2018 Jun; 199(6):1417-1425. PubMed ID: 29410294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer.
    Gild P; Cole AP; Krasnova A; Dickerman BA; von Landenberg N; Sun M; Mucci LA; Lipsitz SR; Chun FK; Nguyen PL; Kibel AS; Choueiri TK; Basaria S; Trinh QD
    J Urol; 2018 Sep; 200(3):573-581. PubMed ID: 29673944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
    Duchesne GM; Woo HH; King M; Bowe SJ; Stockler MR; Ames A; D'Este C; Frydenberg M; Loblaw A; Malone S; Millar J; Tai KH; Turner S
    Lancet Oncol; 2017 Sep; 18(9):1192-1201. PubMed ID: 28760403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.
    Ravi P; Karnes RJ; Rangel LJ; Pagliaro LC
    J Urol; 2018 Nov; 200(5):1075-1081. PubMed ID: 29709664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Androgens and Antiandrogens influence on COVID-19 disease in men].
    Rozhivanov RV; Andreeva EN; Melnichenko GA; Mokrysheva NG
    Probl Endokrinol (Mosk); 2020 Oct; 66(4):77-81. PubMed ID: 33351362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.